NCT02441335

Brief Summary

The goal of this study is to examine how cellular dysfunction can lead to preterm birth. Women with singleton pregnancies with spontaneous preterm labor, preterm premature rupture of membranes, and cervical insufficiency (20 to 36-6/7 weeks gestation), and term deliveries (greater than 38 weeks) will be enrolled. Medical/obstetric history and pregnancy outcomes will be recorded. Maternal blood, urine and cervical cells (enrollment); cord blood and placental biopsy (delivery) will be collected.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
705

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 6, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 12, 2015

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
Last Updated

October 7, 2019

Status Verified

October 1, 2019

Enrollment Period

4.6 years

First QC Date

April 6, 2015

Last Update Submit

October 2, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • Biogenetics

    The role of biogenetics in pregnancy and what are the perturbations in cell metabolism that lead to spontaneous preterm birth.

    5 years

  • Microbiome

    The interactions between the microbiome (oral, gut, cervicovaginal, and placental) and host metabolic function in pregnancy.

    5 years

  • Cervical remodeling

    How the interactions between cell metabolism and the microbiome influence cervical remodeling and placental function leading to spontaneous preterm delivery.

    5 years

  • Genetics and Environmental factors

    How genetic and environmental factors influence the metabolic function of reproductive tissues leading to spontaneous preterm delivery.

    5 years

Study Arms (3)

Group 1 (Preterm labor, PPROM, cervical insufficiency)

Singleton pregnancy between 20 0/7 36 6/7 weeks gestational age who is admitted with PTL or cervical insufficiency (Equal or greater than 2 cm dilated) or PPROM

Group 2 (Term labor)

Admitted to the hospital with spontaneous labor (regular contractions, cervical dilation) or spontaneous rupture of membranes

Group 3 (PTB-medically indicated)

Singleton pregnancy between 20 0/7 34 5/6 weeks gestational age who is admitted with a medically indicated preterm birth (IOL for abruption, non reassuring fetal heart tones, intrauterine growth restriction, preeclampsia, trauma, etc.)

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

At HUP, there are approximately 4,200 deliveries a year, of which approximately 10 percent (420) deliver preterm. Among these preterm births, two-thirds (280) are spontaneous, which is the focus of our research. Many women who ultimately have a preterm birth, first present with preterm labor. Women who have advanced dilatation, preterm rupture of membranes, etc are at high risk for having a preterm birth. The investigators anticipate, based on the number of spontaneous preterm births at HUP per year, enrolling about 40-50% of those eligible and understanding that about 40% of those enrolled will have a preterm birth, we should be able to enroll about 112 women per year over 5 years. The coordinators will enroll cases who are admitted to the hospital with PTL, PPROM, or cervical insufficiency at 20-0/7 to 36-6/7 weeks.

You may qualify if:

  • years of age
  • Singleton pregnancy between 20 0/7 and 36 6/7 weeks gestational age who is admitted with preterm labor or cervical insufficiency (greater than 2 cm dilation) or Preterm Premature Rupture of Membranes

You may not qualify if:

  • Multiple gestation
  • Fetal chromosomal abnormality
  • Major fetal anomaly
  • Intra-uterine fetal demise
  • Gestational hypertension/preeclampsia
  • Controls:
  • years of age
  • Singleton pregnancy that delivers at term (38 to 41 weeks gestational age)
  • Admitted to the hospital with spontaneous labor (regular contractions, cervical dilation) or spontaneous rupture of membranes
  • Multiple gestation
  • Fetal chromosomal abnormality
  • Major fetal anomaly
  • Intra-uterine fetal demise
  • Intra-uterine growth restriction
  • Gestational hypertension/preeclampsia
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

1\. Collect blood, urine and cervicovaginal cells from women with preterm labor and term labor in order to investigate: 1. What is the role of bioenergetics in pregnancy and what are the pertubations in cell metabolism that lead to spontaneous preterm birth 2. What are the interactions between the microbiome (oral, gut, cervicovaginal, and placental) and host metabolic function in pregnancy 3. How do interactions between cell metabolism and the microbiome influence cervical remodeling and placental function leading to spontaneous preterm delivery 4. What genetic and environmental factors influence the metabolic function of reproductive tissues leading to spontaneous preterm delivery

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Michal Elovitz, MD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2015

First Posted

May 12, 2015

Study Start

January 1, 2015

Primary Completion

August 1, 2019

Study Completion

August 1, 2019

Last Updated

October 7, 2019

Record last verified: 2019-10

Locations